Authors: Hadlock, KG Gish, R Rowe, J Rajyaguru, SS Newsom, M Warford, A Foung, SKH

Citation: Kg. Hadlock et al., Cross-reactivity and clinical impact of the antibody response to hepatitisC virus second envelope glycoprotein (E2), J MED VIROL, 65(1), 2001, pp. 23-29

Authors: Shafer, RW Hertogs, K Zolopa, AR Warford, A Bloor, S Betts, BJ Merigan, TC Harrigan, R Larder, BA

Citation: Rw. Shafer et al., High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samplesfrom heavily treated patients, J CLIN MICR, 39(4), 2001, pp. 1522-1529

Authors: Shafer, RW Warford, A Winters, MA Gonzales, MJ

Citation: Rw. Shafer et al., Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals, J VIROL MET, 86(2), 2000, pp. 143-153

Authors: Edwards, BM Main, SH Cantone, KL Smith, SD Warford, A Vaughan, TJ

Citation: Bm. Edwards et al., Isolation and tissue profiles of a large panel of phage antibodies bindingto the human adipocyte cell surface, J IMMUNOL M, 245(1-2), 2000, pp. 67-78

Authors: Zolopa, AR Shafer, RW Warford, A Montoya, JG Hsu, P Katzenstein, D Merigan, TC Efron, B

Citation: Ar. Zolopa et al., HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed, ANN INT MED, 131(11), 1999, pp. 813